Company / EPS (Diluted)
Jaguar Health, Inc. EPS (Diluted) History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$130.69
FY2025
5-year range
-$2678.17 / -$9.01
FY2021-FY2025
Trend
+95.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) returned to growth in FY2025 after 2 years of decline, reaching $-130.69.
Based on SEC 10-K filings.
-130.69 in FY2025.
Declined from $-88.22 to $-130.69 over the past 3 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) increased 95.1% year-over-year.
- Peak eps (diluted) was recorded in FY2017.
- Lowest eps (diluted) in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.49 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$130.69 | +95.1% |
| FY2024 | -$2678.17 | -2935.8% |
| FY2022 | -$88.22 | -879.1% |
| FY2020 | -$9.01 | +94.1% |
| FY2019 | -$153.27 | -1919.4% |
| FY2018 | -$7.59 | -462.2% |
| FY2017 | -$1.35 | +50.0% |
| FY2016 | -$2.70 | +16.7% |
| FY2015 | -$3.24 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026